SLR Investment Corp. SLRC FINANCIAL
Company Overview
SLR Investment Corp. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, leveraged buyouts, acquisitions, recapitalizations, general refinancing, growth capital and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate activities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non-precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $25million. The fund invests in companies with debt investments between $10 million and $50 million with revenues between $50 million and $1000 million and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.
Why Investors Should Care
Net profit has compounded at 11.6% per year over the last five years.
Trades at a P/E of 7.7, below the sector median of 14.5.
Maintains a net profit margin of 35.2%.
Offers a dividend yield of 10.98%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -9.4%, earnings -66.2%.
- 5-Year Trend Long-term compounding — profit CAGR 11.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -9.40% |
Compounded Profit Growth
| 5 Years: | 11.64% |
| 1 Year: | -66.20% |
Stock Price Performance
| 1 Year: | -15.65% |
| 6 Months: | -8.48% |
| 3 Months: | +0.70% |
| 1 Month: | -2.78% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.11 · Neutral
P/E of 7.66 is below the sector median of 14.52 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 35.2%.
- Profit CAGR of 11.6% over 5 years.
- Attractive dividend yield of 10.98%.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SLRC SLR Investment Corp. FINANCIAL | 12.57 | 7.66 | $685.75M | 10.98% | - | 7.47% | - | 11.64% |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 358.64 | 15.37 | $953.34B | 1.68% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 506.03 | 15.07 | $707.59B | 0.00% | - | 10.50% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 374.00 | 31.86 | $637.34B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 579.21 | 31.82 | $503.60B | 0.60% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.68 | 14.48 | $438.31B | 2.03% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 759,350.00 | 15.07 | $384.00B | 0.00% | - | 10.50% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 107.11 | 15.30 | $367.34B | 3.62% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 217.72 | 17.59 | $342.26B | 2.15% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | - | - | - | - | - | 6.82M | 19.00M | 26.95M | 27.87M | 23.23M | 22.05M | 19.93M | 24.23M | 23.30M | 17.12M | 8.27M |
| Diluted EPS | 0.44 | 0.32 | 0.04 | -0.29 | 0.25 | 0.13 | 0.35 | 0.49 | 0.51 | 0.43 | 0.40 | 0.37 | 0.44 | 0.43 | 0.31 | 0.15 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Net Income | - | 59.57M | 18.34M | 76.39M | 95.76M | 92.54M |
| Diluted EPS | 0.37 | 1.41 | 0.35 | 1.40 | 1.76 | 1.70 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | 2.01B | 2.54B | 2.52B | 2.45B | 2.57B |
| Cash & Equivalents | 1.99B | 2.50B | - | - | - |
| Long Term Debt | 812.04M | 1.09B | 1.18B | 1.03B | 1.15B |
| Total Liabilities | 1.17B | 1.54B | 1.54B | 1.46B | 1.58B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -61.37M | -135.10M | 91.06M | -76.88M | 309.31M | -72.02M |
| Financing Cash Flow | 13.79M | 69.26M | 14.34M | -7.30M | -239.20M | 22.05M |
| Share Buybacks | 0 | 0 | 3.04M | 10.00K | 0 | 0 |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | - | - | - | - | - | - |
| ROCE % | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Thornburg Investment Management Inc. | 8.63% | 4.71M | $58.95M |
| 2 | JPMORGAN CHASE & CO | 2.29% | 1.25M | $15.62M |
| 3 | Van Eck Associates Corporation | 2.02% | 1.10M | $13.82M |
| 4 | UBS Group AG | 1.13% | 614.51K | $7.69M |
| 5 | Aristotle Capital Boston, LLC | 1.13% | 613.75K | $7.68M |
| 6 | Franklin Resources, Inc. | 1.01% | 549.09K | $6.87M |
| 7 | Muzinich & Co., Inc. | 1.00% | 544.21K | $6.81M |
| 8 | Condor Capital Management | 0.85% | 462.36K | $5.79M |
| 9 | Legal & General Group PLC | 0.82% | 446.12K | $5.59M |
| 10 | Sumitomo Mitsui Trust Group, Inc. | 0.70% | 381.48K | $4.78M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SLRC
BlackRock Inc. Acquires New Holdings in SLR Investment Corp. $SLRC - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNT2ZXV1FxQ29zcFZSaTMtenRzWWFNcDV1cjBzLUk3VWY1VXFEQVNWQTN6ZHV6RTlUXzhDckNjQ0JWOGNFb196bUNDc3J2VTlJQnBvM3ZSdFpEbTdOZlZhcnFMd0Y4Y3dwMGtpRS1aVnFMRXZMTkFmazFpM2FsOWpUSWNrMFNuWVlXeWV4R0…
Understanding Momentum Shifts in (SLRC) - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQRkgwTmtVeGlCcWE4c1UtZk1ZZlg3MjlhMFhYbS1qTU9ucEltdzFqdWZlTW1oV25pVFp0dy0yNDlzcWNuNEJVOFpGT0tvX2RxUnRjNTRscDFPZEJBZnZPQWllWlowLWNpQUtsWUI2aHNvNFlNZlBPVkxSV3hhQjJ6TFVBVzFmc182SFJVVG…
SLRC faces rate headwinds yet keeps dividend flat; here’s what’s propping up the stock - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQRW1jUHhRaWZaTldOQjdfcGg5VkZ3S1hJU1VWOFdPeVBPTzJxOW5tRm1DZnptVmtLck16Ml8yTzd5Rk9KUWZiVl9SOVlTYVk2MjhfMHU5SnNyRDYwaXdrcXZ5VE9oUzBXVWdEU0NoTDdIbVgxV1ItemdSVjdjRE9xbUplRlNKbGIwd1dZY1…
SLR Investment Stock: Better Days Ahead (NASDAQ:SLRC) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxNNGwtak1WVFdvQ25CZlhPa2Z1NHFlU1ptaVRKQmlId1JRc3RRV0ZZSzFoR1dEeU9icndYQzVrRUItaDM1UVU0WmVwa2VlbE1XZlNwVmUzRENtZF92X0tRR05LcF83ZVZncGR3QWJjZFBCZ1oxcmxKSDI1MjRvaEJiNUhleWc?oc=5" targ…
SLR Investment Q2 Earnings Per Share Falls To $0.15 - quiverquant.com
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQb1RiSUJBTWhjVVlhMUcxR2NTUlpKMUxZNzJKVFJ5WDZRc2VLbm9MRmxkdVBrRVRqRHB4eG9mMTlzWGE5aGs4ZlIwLWJkeUVwcGJmeWN5UDQ1MkZvRWgzRWJZSWZwTkVNamNPQlpmbHlJeG41VzhaTmJjQmVQczE1ZjBNMWY3LUZxWDBsQw…
Legal & General Group Plc Takes $5.52 Million Position in SLR Investment Corp. $SLRC - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxNeHZIYWh3VmhwcTN0a0lVUUoySktVZ1l1dXRjN3phSFh4SDJxbFFNUGQ1THdaRGFDOUlRbi1OSmw5MlJnb1NUQXpseE9pRlQ3OHc1Y04zMklQam9tbWZpbm5GTkU1SEU1aG9DUFp6LXk0dkY0OHQ2TW9zUWx1clowNTFNZkRVSjFrR2t2TX…
SLRC — Frequently Asked Questions
What is the current share price of SLR Investment Corp. (SLRC)?
As of 2026-09-07 16:24 PDT, SLR Investment Corp. (SLRC) trades at $12.57 on NasdaqGS. Its 52-week range is $12.21 to $15.74.
What is the market capitalisation of SLRC?
SLR Investment Corp. (SLRC) has a market capitalisation of $685.75M on NasdaqGS.
What is the P/E ratio of SLRC?
SLRC trades at a trailing price-to-earnings (P/E) ratio of 7.66. The industry average P/E is 14.52. Its price-to-book (P/B) ratio is 0.72.
Does SLRC pay a dividend?
SLR Investment Corp. (SLRC) currently offers a dividend yield of 10.98%.
What is the return on equity (ROE) of SLRC?
SLRC has a return on equity (ROE) of 7.47%.
Is SLRC a good stock to buy?
This page provides a data-driven analysis of SLR Investment Corp. (SLRC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.